Neogenix Pharmaceuticals Private Limited
Provides human health and social care services since 2016, based in Lucknow, Uttar Pradesh.
2016 | Lucknow, Uttar Pradesh (India) | Active
Neogenix Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.33 M
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 3.06%
- Profit Growth -28.73%
- Ebitda -34.62%
- Net Worth 1.07%
- Total Assets -2.53%
About Neogenix Pharmaceuticals
Neogenix Pharmaceuticals Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 March 2016 (Eight years and 11 months 12 days old ). Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.33 M, as per Ministry of Corporate Affairs (MCA) records.
Ankita Srivastva and Suman Singh serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74900UP2016PTC140298
- Company No.
293063
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Mar 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Healthcare
Who are the key members and board of directors at Neogenix Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ankita Srivastva  | Director | 23-Mar-2016 | Current |
| Suman Singh | Director | 24-Aug-2020 | Current |
Financial Performance of Neogenix Pharmaceuticals.
Neogenix Pharmaceuticals Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 3.06% increase. The company also saw a substantial fall in profitability, with a 28.73% decrease in profit. The company's net worth moved up by a moderate rise of 1.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neogenix Pharmaceuticals?
In 2020, Neogenix Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Neogenix Pharmaceuticals?
Unlock and access historical data on people associated with Neogenix Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neogenix Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neogenix Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Neogenix Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Neogenix Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Neogenix Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Kanpur.
- Director Appointment
Suman Singh was appointed as a Director was appointed as a Director on 24 Aug 2020 & has been associated with this company since 4 years 6 months .
- Director Appointment
Ankita Srivastva was appointed as a Director was appointed as a Director on 23 Mar 2016 & has been associated with this company since 8 years 11 months .
- Company Incorporation
Neogenix Pharmaceuticals Private Limited was registered on 23 Mar 2016 with Roc Kanpur & aged 8 years 11 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Neogenix Pharmaceuticals Private Limited?
Neogenix Pharmaceuticals Private Limited was incorporated on 23 Mar 2016.
What is authorized share capital and paid-up capital of Neogenix Pharmaceuticals Private Limited?
The authorized share capital of Neogenix Pharmaceuticals Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.33 M.
Who are the current board members & directors of Neogenix Pharmaceuticals Private Limited?
Currently 2 directors are associated with Neogenix Pharmaceuticals Private Limited.
- Ankita Srivastva
- Suman Singh
What is the registered address of Neogenix Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Neogenix Pharmaceuticals Private Limited is H No.-632/46/1 Kamta, Chinhat India, Lucknow, Uttar Pradesh, 226028.
What is the corporate identification number (CIN) and company number of Neogenix Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Neogenix Pharmaceuticals Private Limited is U74900UP2016PTC140298 and the company number is 293063 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Neogenix Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2020, the revenue trend for Neogenix Pharmaceuticals Private Limited has risen by 3.06%.
What change has been observed in the net worth of Neogenix Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2020 indicates that The net worth of Neogenix Pharmaceuticals Private Limited has experienced an upsurge of 1.07%.
When was the last Balance Sheet of Neogenix Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Neogenix Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.